EUVIMEDEUVIMED entdecken
Crossref

Self‐Oxygenating PROTAC Microneedle for Spatiotemporally‐Confined Protein Degradation and Enhanced Glioblastoma Therapy

Xingyu Jiang, Yi Lai, Wenzheng Xia, Wenfang Yang, Junjue Wang, Jiaxing Pan, Qian Zhao, Feng Zhou, Shiqin Li, Shunan Zhang, Jing Gao, Yinyan Wang und 4 weitere

Advanced Materials · 2025-04 · 37 (13)

DOI: 10.1002/adma.202411869 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 03.03.2025. Verfasst von Xingyu Jiang und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200241, China. Hauptthemen laut MEDLINE: Glioblastoma, Oxygen, Needles, Brain Neoplasms. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most aggressive subtype of primary brain tumors, which marginally respond to standard chemotherapy due to the blood‐brain barrier (BBB) and the low tumor specificity of the therapeutics. Herein, a double‐layered microneedle (MN) patch is rationally engineered by integrating acid and light dual‐activatable PROteolysis TArgeting Chimera (PROTAC) nanoparticles and self‐oxygenating BSA‐MnO 2 (BM) nanoparticles for GBM treatment. The MN is administrated at the tumor site to locally deliver the PROTAC prodrug and BM nanoparticles. The PROTAC nanoparticles are rapidly released from the outer layer of the MN and specifically activated in the acidic intracellular environment of tumor cells. Subsequently, near‐infrared light activates the photosensitizer to produce singlet oxygen ( 1 O 2 ) through photodynamic therapy (PDT), thereby triggering spatiotemporally‐tunable degradation of bromodomain and extraterminal protein 4 (BRD4). The BM nanoparticles, in the inner layer of the MN, serve as an oxygen supply station, and counteracts tumor hypoxia by converting hydrogen peroxide (H 2 O 2 ) into oxygen (O 2 ), thus promoting PDT and PROTAC activation. This PROTAC prodrug‐integrated MN significantly inhibits tumor growth in both subcutaneous and orthotopic GBM tumor models. This study describes the first spatiotemporally‐tunable protein degradation strategy for highly efficient GBM therapy, potentially advancing precise therapy of other kinds of refractory brain tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaOxygenNeedlesBrain NeoplasmsAnimalsHumansCell Line, TumorProteolysisMiceNanoparticlesProdrugsPhotosensitizing AgentsPhotochemotherapyManganese CompoundsOxidesSerum Albumin, BovineTranscription FactorsSinglet OxygenHydrogen Peroxide

Stichwörter der Autor:innen

acid‐activatable photodynamic therapydouble‐layered microneedleglioblastoma therapylight‐activatable PROTAC prodrugprotein degradation

Substanzen

ProdrugsPhotosensitizing AgentsManganese CompoundsOxygenOxidesSerum Albumin, BovineTranscription FactorsSinglet OxygenHydrogen Peroxide

Autor:innen und Institutionen

  • School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200241, China.
  • State Key Laboratory of Chemical Biology and Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
  • School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
  • Institute of Biomedical Health Technology and Engineering and Institute of Systems and Physical Biology, Shenzhen Bay Laboratory, Shenzhen, 518067, China.

ORCID-Profile: Zhiai Xu

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Jiang, X., Lai, Y., Xia, W., Yang, W., Wang, J., Pan, J., Zhao, Q., Zhou, F., Li, S., Zhang, S., Gao, J., Wang, Y., Zan, T., Xu, Z. P., Yu, H., & Xu, Z. (2025). Self‐Oxygenating PROTAC Microneedle for Spatiotemporally‐Confined Protein Degradation and Enhanced Glioblastoma Therapy. Advanced Materials, 37(13). https://doi.org/10.1002/adma.202411869

Vancouver

Jiang X, Lai Y, Xia W, Yang W, Wang J, Pan J, et al. Self‐Oxygenating PROTAC Microneedle for Spatiotemporally‐Confined Protein Degradation and Enhanced Glioblastoma Therapy. Advanced Materials. 2025;37(13). doi:10.1002/adma.202411869

BibTeX
@article{Jiang2025,
  author = {Jiang, Xingyu and Lai, Yi and Xia, Wenzheng and Yang, Wenfang and Wang, Junjue and Pan, Jiaxing and Zhao, Qian and Zhou, Feng and Li, Shiqin and Zhang, Shunan and Gao, Jing and Wang, Yinyan and Zan, Tao and Xu, Zhi Ping and Yu, Haijun and Xu, Zhiai},
  title = {Self‐Oxygenating PROTAC Microneedle for Spatiotemporally‐Confined Protein Degradation and Enhanced Glioblastoma Therapy},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {13},
  doi = {10.1002/adma.202411869}
}
Kostenlos starten →